# | Title | Journal | Year | Citations |
---|
1 | Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies | Clinical Gastroenterology and Hepatology | 2015 | 1,199 |
2 | Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease | Gastroenterology | 2015 | 725 |
3 | Wilson disease | Nature Reviews Disease Primers | 2018 | 466 |
4 | A multicenter study to define sarcopenia in patients with end‐stage liver disease | Liver Transplantation | 2017 | 343 |
5 | Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis | Nature Genetics | 2013 | 339 |
6 | No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial | Gastroenterology | 2014 | 260 |
7 | A dose-response study of consuming high-fructose corn syrup–sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults | American Journal of Clinical Nutrition | 2015 | 214 |
8 | Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis | European Radiology | 2016 | 195 |
9 | Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations | Journal of Hepatology | 2011 | 180 |
10 | A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab | Clinical Gastroenterology and Hepatology | 2013 | 168 |
11 | IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy | Hepatology | 2014 | 168 |
12 | Diagnosis and management of pouchitis1 1Abbreviations used in this paper: EIM, extraintestinal manifestations; FAP, familial adenomatous polyposis; IL, interleukin; IPAA, ileal pouch anal anastomosis; pANCA, serum antineutrophil cytoplasmic antibody-perinuclear staining pattern; PAS, Pouchitis Activity Score; PDAI, Pouchitis Disease Activity Index; PSC, primary sclerosing cholangitis; QOL, quality of life; SCFA, small chain fatty acids. | Gastroenterology | 2003 | 166 |
13 | Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study | Gastroenterology | 2019 | 151 |
14 | National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States | JAMA Internal Medicine | 2019 | 150 |
15 | Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta‐analysis | Hepatology | 2015 | 139 |
16 | Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid | Hepatology | 2012 | 130 |
17 | Noninvasive Assessment of Hepatic Steatosis | Clinical Gastroenterology and Hepatology | 2009 | 129 |
18 | Extended Criteria Donors in Liver Transplantation | Clinics in Liver Disease | 2017 | 128 |
19 | Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease | American Journal of Gastroenterology | 2002 | 127 |
20 | EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study | Gastrointestinal Endoscopy | 2017 | 124 |
21 | Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer | Rapid Communications in Mass Spectrometry | 2010 | 123 |
22 | Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection | JAMA Internal Medicine | 2017 | 120 |
23 | A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis | Journal of Hepatology | 2020 | 111 |
24 | Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis | Hepatology | 2007 | 109 |
25 | The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C | Journal of Hepatology | 2004 | 101 |
26 | Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma | Experimental and Molecular Pathology | 2010 | 100 |
27 | Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease | Hepatology | 2008 | 99 |
28 | Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis | Clinical Gastroenterology and Hepatology | 2021 | 95 |
29 | Height Contributes to the Gender Difference in Wait-List Mortality Under the MELD-Based Liver Allocation System | American Journal of Transplantation | 2010 | 88 |
30 | Outcomes in liver transplantation: Does sex matter? | Journal of Hepatology | 2015 | 79 |
31 | Pneumocystis carinii Pneumonia During Maintenance Anti–Tumor Necrosis Factor-α Therapy with Infliximab for Crohn’s Disease | Inflammatory Bowel Diseases | 2004 | 76 |
32 | Epstein–Barr Virus (EBV) Related Acute Liver Failure: A Case Series from the US Acute Liver Failure Study Group | Digestive Diseases and Sciences | 2014 | 75 |
33 | Review article: impact of exercise on physical frailty in patients with chronic liver disease | Alimentary Pharmacology and Therapeutics | 2019 | 72 |
34 | Multisociety guideline on reprocessing flexible GI endoscopes and accessories | Gastrointestinal Endoscopy | 2021 | 68 |
35 | Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis | Hepatology | 2014 | 67 |
36 | Liver Transplantation in the Obese Cirrhotic Patient | Transplantation | 2017 | 67 |
37 | Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials | European Radiology | 2012 | 66 |
38 | Anti‐kelch‐like 12 and anti‐hexokinase 1: novel autoantibodies in primary biliary cirrhosis | Liver International | 2015 | 66 |
39 | Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites | Scientific Reports | 2017 | 66 |
40 | Feasibility and safety of microforceps biopsy in the diagnosis of pancreatic cysts | Gastrointestinal Endoscopy | 2018 | 66 |
41 | Hepatitis B Virus (HBV) Infection in Asian and Pacific Islander Americans (APIAs): How Can We Do Better for This Special Population | American Journal of Gastroenterology | 2008 | 63 |
42 | The Impact of Race/Ethnicity on the Clinical Epidemiology of Autoimmune Hepatitis | Journal of Clinical Gastroenterology | 2012 | 61 |
43 | Common Variable Immunodeficiency and Liver Involvement | Clinical Reviews in Allergy and Immunology | 2018 | 58 |
44 | MELD-Based Liver Allocation: Who Is Underserved? | Seminars in Liver Disease | 2006 | 57 |
45 | Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies | Clinical Gastroenterology and Hepatology | 2016 | 57 |
46 | Endoscopists systematically undersample patients with long-segment Barrett’s esophagus: an analysis of biopsy sampling practices from a quality improvement registry | Gastrointestinal Endoscopy | 2019 | 56 |
47 | The Range and Reproducibility of the Liver Frailty Index | Liver Transplantation | 2019 | 56 |
48 | DNA methylation alterations in Alzheimer’s disease | Environmental Epigenetics | 2017 | 54 |
49 | Physical Function, Physical Activity, and Quality of Life After Liver Transplantation | Liver Transplantation | 2020 | 53 |
50 | Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group | Clinical Gastroenterology and Hepatology | 2021 | 52 |